Javascript must be enabled to continue!
Abstract 2579: Kras expression level regulates heparanase activity
View through CrossRef
Abstract
Introduction: Sarcomas are locally and systemically aggressive, significantly interacting with extracellular matrix. The purpose of this study is to quantify the expression of heparanase by K-ras expressing sarcoma cells.
Methods: Balb/c3T3 and K234 (Ki-ras-transformed Balb/c 3T3) cells (ATCC) were cultured using DMEM with 5% FBS. Heparanase assays were performed with the heparan degrading enzyme assay kit (cat# MK412; Takara) on cell lysate for each cell line according manufacturer protocol. Dhmaracon on-Target Plus SMARTpool siRNA was used to knock down Kras. Total RNA was isolated with Qiagen RNeasy kit, cDNA was made using Invitrogen SuperScript™ III First-Strand Synthesis System, real time RT-PCR was done by use SYBR green Master Mix and Applied Biosystems® 7500 system, mRNA level for HPSE and PPBP was measured by RTPCR. The UCSC genome browser was used to show HPSE sequence and primer location.
Results: The heparan degrading activity of lysate from K234 cells was 20-30 times higher than from Balb/c3T3 cells. However, nine pairs of primers for mHPSE RT-PCR results show that mHPSE mRNA is expressed differently in Balb/c3T3 and K234 cell with K234 cell mHPSE mRNA level is lower than in Balb/c 3T3 cells. The mRNA sequence is the same in these two cell lines, however. Using siRNA knock down of greater than 80% Kras from K234 and Balb/c3T3 cells, the heparanase activity of lysate decreased by 78% in K234 cells, and 25% in Balb/c3T3 cells. Kras knock down also changed cell morphology in both cell lines, and changed the mRNA levels of HPSE, PPBP and some EMT markers.
Conclusion: Kras overexpressed in K234 cells is associated with increase in heparanase activity, and knock down of Kras decreases heparanase activity. However, heparanase activity does not correlate with HPSE (heparanase 1) expression level, so there is likely another mechanism(s) for Kras expression to regulate heparanase activity.
Citation Format: Donghong Ju, Mary A. Kosir. Kras expression level regulates heparanase activity [abstract]. In: Proceedings of the Annual Meeting of the American Association for Cancer Research 2020; 2020 Apr 27-28 and Jun 22-24. Philadelphia (PA): AACR; Cancer Res 2020;80(16 Suppl):Abstract nr 2579.
Title: Abstract 2579: Kras expression level regulates heparanase activity
Description:
Abstract
Introduction: Sarcomas are locally and systemically aggressive, significantly interacting with extracellular matrix.
The purpose of this study is to quantify the expression of heparanase by K-ras expressing sarcoma cells.
Methods: Balb/c3T3 and K234 (Ki-ras-transformed Balb/c 3T3) cells (ATCC) were cultured using DMEM with 5% FBS.
Heparanase assays were performed with the heparan degrading enzyme assay kit (cat# MK412; Takara) on cell lysate for each cell line according manufacturer protocol.
Dhmaracon on-Target Plus SMARTpool siRNA was used to knock down Kras.
Total RNA was isolated with Qiagen RNeasy kit, cDNA was made using Invitrogen SuperScript™ III First-Strand Synthesis System, real time RT-PCR was done by use SYBR green Master Mix and Applied Biosystems® 7500 system, mRNA level for HPSE and PPBP was measured by RTPCR.
The UCSC genome browser was used to show HPSE sequence and primer location.
Results: The heparan degrading activity of lysate from K234 cells was 20-30 times higher than from Balb/c3T3 cells.
However, nine pairs of primers for mHPSE RT-PCR results show that mHPSE mRNA is expressed differently in Balb/c3T3 and K234 cell with K234 cell mHPSE mRNA level is lower than in Balb/c 3T3 cells.
The mRNA sequence is the same in these two cell lines, however.
Using siRNA knock down of greater than 80% Kras from K234 and Balb/c3T3 cells, the heparanase activity of lysate decreased by 78% in K234 cells, and 25% in Balb/c3T3 cells.
Kras knock down also changed cell morphology in both cell lines, and changed the mRNA levels of HPSE, PPBP and some EMT markers.
Conclusion: Kras overexpressed in K234 cells is associated with increase in heparanase activity, and knock down of Kras decreases heparanase activity.
However, heparanase activity does not correlate with HPSE (heparanase 1) expression level, so there is likely another mechanism(s) for Kras expression to regulate heparanase activity.
Citation Format: Donghong Ju, Mary A.
Kosir.
Kras expression level regulates heparanase activity [abstract].
In: Proceedings of the Annual Meeting of the American Association for Cancer Research 2020; 2020 Apr 27-28 and Jun 22-24.
Philadelphia (PA): AACR; Cancer Res 2020;80(16 Suppl):Abstract nr 2579.
Related Results
Abstract 1708: Heparanase regulates response to chemotherapy in myeloma
Abstract 1708: Heparanase regulates response to chemotherapy in myeloma
Abstract
Following therapy, essentially all multiple myeloma patients relapse due to a population of chemoresistant cells leading to eventual patient death. Our lab ...
Abstract 2395: A bioluminescent probe for detection and imaging of heparanase enzymatic activity
Abstract 2395: A bioluminescent probe for detection and imaging of heparanase enzymatic activity
Abstract
Cancers of all types have been shown to overexpress the carbohydrate-processing enzyme heparanase during angiogenesis and invasion, and this enzymatic activ...
Kras Plays An Important Role In Generating Differentiated Blood Cells
Kras Plays An Important Role In Generating Differentiated Blood Cells
Abstract
Background
Kras is a small GTPase essential for mouse embryonic development. Although Kras-/- fetal liver cells reconst...
Abstract 2441: The myCAF and ECM landscape in KRAS-mutated cancer: Utilizing liquid biomarkers to track KRAS-induced fibrosis and KRAS inhibitor efficacy
Abstract 2441: The myCAF and ECM landscape in KRAS-mutated cancer: Utilizing liquid biomarkers to track KRAS-induced fibrosis and KRAS inhibitor efficacy
Abstract
Background:
KRAS-driven cancer represents ∼25% of cancers, with high rates in pancreatic cancer (PDAC), colorect...
Involvement of Heparanase in Early Pregnancy Losses
Involvement of Heparanase in Early Pregnancy Losses
Abstract
Heparanase activity is implicated in cell invasion, tumor metastasis and angiogenesis. Recently, we have reported that heparanase stimulates tissue factor (...
Abstract 5735: Novel KRAS G12D degrader ASP3082 demonstrates in vivo, dose-dependent KRAS degradation, KRAS pathway inhibition, and antitumor efficacy in multiple KRAS G12D-mutated cancer models
Abstract 5735: Novel KRAS G12D degrader ASP3082 demonstrates in vivo, dose-dependent KRAS degradation, KRAS pathway inhibition, and antitumor efficacy in multiple KRAS G12D-mutated cancer models
Abstract
KRAS is one of the most frequently mutated oncogenes in various cancers. Among KRAS mutations, KRAS G12D is the most frequent driver mutation and is found i...
Data from Heparanase Augments Epidermal Growth Factor Receptor Phosphorylation: Correlation with Head and Neck Tumor Progression
Data from Heparanase Augments Epidermal Growth Factor Receptor Phosphorylation: Correlation with Head and Neck Tumor Progression
<div>Abstract<p>Heparanase is an endoglycosidase that specifically cleaves heparan sulfate side chains, a class of glycosaminoglycans abundantly present in the extracel...
Heparanase promotes glioma progression via enhancing CD24 expression
Heparanase promotes glioma progression via enhancing CD24 expression
Heparanase is an endo‐β‐d‐glucuronidase that cleaves heparan sulfate (HS) side chains of heparan sulfate proteoglycans. Compelling evidence tie heparanase levels with all steps of ...

